Page last updated: 2024-08-21

adamantane and Diabetic Angiopathies

adamantane has been researched along with Diabetic Angiopathies in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's8 (88.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bombelli, M; Dell'Oro, R; Gamba, P; Grassi, G; Maloberti, A; Mancia, G; Nicoli, F; Villa, P1
Bhatt, DL; Braunwald, E; Davidson, J; Frederich, B; Hirshberg, B; Mosenzon, O; Ohman, P; Price, DL; Raz, I; Scirica, BM; Stahre, CI; Steg, PG; Udell, JA1
Dhindsa, S; Jialal, I1
Avogaro, A; Dardano, A; de Kreutzenberg, SV; Del Prato, S1
Bhatt, DL; Bonnici, F; Braunwald, E; Cahn, A; Frederich, R; Hirshberg, B; Kumar, KM; Leiter, LA; Mosenzon, O; Raz, I; Scirica, BM; Smahelova, A; Stahre, C; Teoh, H1
Fonseca, VA; John-Kalarickal, J; Wani, JH1
Couturier, A; Dejager, S; Foley, JE; Kothny, W; Ligueros-Saylan, M; Schweizer, A1
Maeda, S; Matsui, T; Yamagishi, S1
Fisman, EZ; Goldenberg, I; Klempfner, R; Leor, J; Tenenbaum, A1

Reviews

3 review(s) available for adamantane and Diabetic Angiopathies

ArticleYear
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes.
    Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:2

    Topics: Adamantane; Aged; Aged, 80 and over; Blood Glucose; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Evidence-Based Medicine; Glycated Hemoglobin; Humans; Hypoglycemia; Nitriles; Practice Guidelines as Topic; Pyrrolidines; Quality of Life; Vildagliptin

2015
Dipeptidyl peptidase-4 as a new target of action for type 2 diabetes mellitus: a systematic review.
    Cardiology clinics, 2008, Volume: 26, Issue:4

    Topics: Adamantane; Animals; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Nitriles; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin

2008
Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population.
    Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:6

    Topics: Adamantane; Cerebrovascular Disorders; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Middle Aged; Nitriles; Pyrrolidines; Randomized Controlled Trials as Topic; Vildagliptin

2010

Trials

3 trial(s) available for adamantane and Diabetic Angiopathies

ArticleYear
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.
    Diabetes/metabolism research and reviews, 2013, Volume: 29, Issue:5

    Topics: Adamantane; Aged; Biomarkers; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Overweight; Prevalence; Risk Factors; Severity of Illness Index

2013
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.
    Diabetes care, 2015, Volume: 38, Issue:6

    Topics: Adamantane; Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Glycated Hemoglobin; Heart Failure; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Stroke; Treatment Outcome

2015
Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease.
    Cardiovascular diabetology, 2012, Jun-06, Volume: 11

    Topics: Adamantane; Adiponectin; Atherosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Humans; Hypoglycemic Agents; Inflammation; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Israel; Matrix Metalloproteinase 9; Metformin; Nitriles; Platelet Function Tests; Prospective Studies; Pyrrolidines; Research Design; Thrombosis; Time Factors; Treatment Outcome; Vildagliptin

2012

Other Studies

3 other study(ies) available for adamantane and Diabetic Angiopathies

ArticleYear
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017, Volume: 24, Issue:4

    Topics: Adamantane; Biomarkers; Blood Glucose; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulse Wave Analysis; Recovery of Function; Time Factors; Treatment Outcome; Vascular Stiffness

2017
No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: potential explanations.
    Metabolic syndrome and related disorders, 2014, Volume: 12, Issue:3

    Topics: Adamantane; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Multicenter Studies as Topic

2014
Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats.
    International journal of cardiology, 2012, Jun-28, Volume: 158, Issue:1

    Topics: Adamantane; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Male; Nitriles; Oxidative Stress; Pyrrolidines; Rats; Rats, Sprague-Dawley; Vildagliptin

2012